The macd is about to cross and the price has consolidated at the 200 MA for several days straight with the 200 appearing to offer support. The price is still well bellow the POC line YTD which in my opinion makes this a low risk entry. Likely resistance at 6.96 and a first target of $7.74
Gain of 117% in two months Pullback of 17% Sideways movement over 19 days Big volume buying on up days May need some more time to firm up after last two days losing the 20-day SMA
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the...
Potential cup & handle. Notice the macd about to cross negative and the long pin bar on 9/25 to the .50 Fib retracement at $4.12 Looking for a retest of $4.12 to go long. Add 1/2 at 4.12 and 1/2 at 3.81 if it doesnt hold.
Looking for a bounce off the 61.8 Fib and retest of that level (2.90-2.91) to go long. The MACD cross can be seen on 4hr and 2hr charts. If that doesnt hold I will do the same at 78.6% 1st target 3.39 2nd 4 Small cap, low float, patented tech... has explosive potential
Looking for morning panic at 4.03 for a nice bounce of 10-20% nice multi green days here is not tomorrow will be stalking for first red day as this is due for some consolidation after recent earnings reportings, things to consider thou is under 1% of the float is short so there are more longs in here if the big is big enough the buyers will be the ones to set off...
Could this go back to $22? with news of FDA clearance...Maybe
EDAP: edap tms sa adr 2018-06-07 17:15:23 Detected possible FDA clearance
Gapped up above yearly resistance at $3.50 and $3.86 Short if it does not hold support at $3.40 Long if it breaks resistance at $4.30 to make a quick profit before reaching $5 resistance
EDAP has recieved FDA clearance on its prostate device. With a price target of $6 this has room to run. Shorts could get trapped. A mourning dip got caused some panic but it appears to be holding the $3.70 range and looking to setup for another break out after the rsi cools down a bit.